Brain Meningioma
Understanding Brain Meningioma (Cerebral Meningioma, Intracranial Meningioma) diagnosis, ICD-10 codes, clinical documentation, and healthcare implications. Find information on Brain Meningioma symptoms, treatment options, and medical coding best practices for accurate clinical documentation. Learn about the different types of Brain Meningiomas and relevant medical terminology for healthcare professionals.
A slow-growing, usually benign tumor arising from the meninges, the membranes surrounding the brain and spinal cord.
Headaches, seizures, vision changes, numbness, weakness, cognitive impairment. Often asymptomatic.
Neurology clinic, neurosurgery department, brain tumor center, hospital.
ICD-10 Code Families
Complete code families applicable to D32.0
When to use each related code
| Description | When to use |
|---|---|
| Brain tumor arising from meninges. | Use for tumors originating from the meninges of the brain. Consider location for more specific codes. |
| Spinal cord tumor from meninges. | Use for tumors of the spinal meninges. Exclude brain meningiomas. Code location specifically. |
| Tumor of nerve sheath. | Use for schwannomas and neurofibromas. Exclude meningiomas. Specify location. |
Best-practice checklist
- ✓Brain Meningioma (ICD-10 C70.9, SNOMED CT 441364009) diagnosis confirmation
- ✓Document meningioma location (convexity, skull base, etc.)
- ✓Record tumor size and imaging characteristics (MRI/CT)
- ✓Symptom documentation (headaches, seizures, neurological deficits)
- ✓If surgery, specify resection extent (Simpson grade)
Common pitfalls to avoid
Using non-specific ICD-10 codes (e.g., C71) instead of precise histology codes (e.g., C70.0) for brain meningioma impacts reimbursement and data accuracy.
Missing documentation specifying laterality (right, left, bilateral) for the meningioma leads to coding errors and potential claim denials.
Discrepancy between documented histology and coded diagnosis (e.g., coding a benign meningioma as malignant) results in inaccurate reporting and affects quality metrics.
Best-practice tips
- 01Code accurately using ICD-10: C70.0-C70.9, D32.0-D33.9 for precise documentation.
- 02Document tumor size, location, and histology for improved CDI and compliance.
- 03Monitor neurologic exams, imaging results for timely intervention and optimal patient care.
- 04Regular follow-up crucial, especially for asymptomatic/small meningiomas, document rationale.
- 05Multidisciplinary approach (neurology, neurosurgery, radiation oncology) enhances outcomes.
Step-by-step checklist
- 1
Verify imaging confirms meningioma (MRI preferred)
- 2
Check for neurological deficits documentation
- 3
Assess WHO grade via pathology report
- 4
Review surgical plan if indicated (size, location)
- 5
Document symptom onset and progression
Ready-to-paste narrative
Patient presents with symptoms suggestive of brain meningioma, including headaches, seizures, and focal neurological deficits. Differential diagnosis includes other intracranial tumors such as gliomas and schwannomas. Magnetic resonance imaging (MRI) of the brain with and without contrast revealed a well-circumscribed, extra-axial mass consistent with a meningioma, measuring [size] cm in diameter, located in the [location - e.g., parasagittal, convexity, skull base] region. The meningioma appears [description - e.g., homogeneously enhancing, dural-based, with surrounding edema]. Clinical findings and imaging characteristics are indicative of a World Health Organization (WHO) grade [I, II, or III] meningioma. The patient's current Karnofsky Performance Status (KPS) is [score]. Treatment options including surgical resection, radiosurgery, and observation were discussed with the patient. The risks and benefits of each approach were explained, and the patient elected to [chosen treatment plan - e.g., proceed with surgical resection, undergo stereotactic radiosurgery, pursue watchful waiting with serial MRIs]. A neurosurgical consultation was obtained, and surgical planning is underway. ICD-10 code C70.1 (Meningioma of cerebral meninges) is documented. CPT codes for the relevant procedures, such as surgical resection (e.g., 61512, 61519) or radiosurgery (e.g., 77372, 77373), will be applied upon completion of the procedure. Continued monitoring for progression of symptoms and tumor growth is recommended. Patient education provided regarding meningioma symptoms, diagnosis, treatment options, prognosis, and follow-up care.
Common questions and answers
What are the most reliable radiological features for differentiating atypical meningioma (WHO Grade II) from benign meningioma (WHO Grade I) on MRI?+
Differentiating atypical meningioma (WHO Grade II) from benign meningioma (WHO Grade I) on MRI can be challenging, but certain radiological features increase suspicion for atypical meningioma. These include increased mitotic activity indirectly visualized as higher cellularity on perfusion-weighted imaging, prominent or irregular borders suggesting brain invasion seen on T1-weighted post-contrast sequences, and heterogeneous texture and signal intensity reflecting necrosis or calcification often visible on both T1 and T2 weighted images. While not definitive, the presence of these findings should raise concern for higher-grade meningioma. Consider implementing a systematic approach for evaluating meningiomas on MRI, incorporating both conventional and advanced imaging techniques like diffusion and perfusion MRI for a comprehensive assessment. Explore how these findings can be integrated with clinical presentation and histopathological analysis for accurate grading and treatment planning.
How do I counsel a patient on the different management options for asymptomatic intracranial meningiomas, including observation, radiosurgery, and surgical resection?+
Counseling patients with asymptomatic intracranial meningiomas requires a nuanced approach considering tumor size, location, patient age, comorbidities, and patient preferences. Observation with serial imaging is often appropriate for small, stable meningiomas. Discuss the risks and benefits of each approach, highlighting that observation involves regular monitoring for growth, while radiosurgery like Gamma Knife or CyberKnife offers targeted radiation to control tumor growth. Surgical resection aims for complete removal but carries risks related to the procedure itself and location of the meningioma within the brain. Emphasize that the optimal approach depends on individual circumstances. Learn more about the latest guidelines for managing asymptomatic intracranial meningiomas to provide evidence-based recommendations tailored to each patient’s specific situation.
What are the key red flags in the clinical presentation of a brain meningioma that suggest a more aggressive subtype or higher risk of recurrence? How does this inform my next steps in diagnosis and management?+
Certain clinical presentations raise suspicion for more aggressive meningioma subtypes or increased recurrence risk. Rapidly progressive neurological deficits, such as seizures, motor weakness, or cognitive changes, warrant prompt investigation. Significant peritumoral edema or signs of brain invasion on imaging should also raise concern. In these cases, obtaining a detailed history, thorough neurological examination, and advanced neuroimaging including MRI with contrast are crucial. Furthermore, consider the possibility of atypical or anaplastic meningiomas and discuss the need for a tissue biopsy or resection to confirm the diagnosis and guide management. Explore how these red flags can be integrated into a clinical decision-making algorithm for brain meningiomas to ensure timely and appropriate intervention, which may include more aggressive surgical resection, radiation therapy, or enrollment in clinical trials.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.